Search this Site

Brand Name(s): Azulfidine; Azulfidine EN-tabs;

Salazopyrin; SAS-500
CAS nº: 599-79-1
(sul fa sal' a zeen)

About Sulfasalazine

This new site is dedicated exclusively to sulfasalazine.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about sulfasalazine on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site also offers you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total sulfasalazine experience! 

Why is this medication prescribed?

Sulfasalazine is used to treat ulcerative colitis and to maintain remission. The delayed-release tablets, Azulfidine® (EN-tabs), are also used to treat rheumatoid arthritis and juvenile rheumatoid arthritis.

The exact way that sulfasalazine works is unknown, but it is believed to reduce the actions of substances in the body that cause inflammation, tissue damage, and diarrhea.

Sulfasalazine is sold under the brand name Azulfidine® in the United States.

See more Product Info

Latest News

Study finds key to easing symptoms of Ross River

AUSTRALIAN researchers believe they have made a major breakthrough in combating the debilitating...

[more]

Conventional Medical Treatment for Colitis

Description: Colitis, or ulcerative colitis as it is also known, is one of the two chronic...

[more]

Arthritis drug may offer a means of reversing liver disease

London - A drug, which is presently used extensively in the treatment of arthritis and inflammatory...

[more]

Analysis: Colitis market to hit $1.1B

Washington -- Emerging drugs from Shire, Procter & Gamble, Isis and PDL BioPharma are set to drive...

[more]

Stubborn Ulcerative Colitis Responds To Arthritis Drug, Review Finds

In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder,...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.